Health Technology Sysmex Corp. Business Summary
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Financial Highlights
Mar 2021
JPY USD Revenue 305,073M 2,876.48M Gross Profit 154,303M 1,454.90M Operating income 50,947M 480.37M Income before tax 51,116M 481.96M Net income 33,142M 312.49M EBITDA 76,522M 721.51M Diluted EPS 158.38 1.49 Dividends Per Share 72 0.67 Total Assets 427,475M 3,868.55M Total liabilities 118,801M 1,075.12M Total equity 307,898M 2,786.40M Operating cash flow 58,813M 554.53M Currency in JPY Currency in USD
Historical Data Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Revenue
249,899M
281,935M
293,506M
301,980M
305,073M
Gross Profit
141,777M
158,949M
161,607M
159,807M
154,303M
Operating income
50,822M
59,947M
60,799M
54,501M
50,947M
Income before tax
48,946M
58,117M
57,955M
49,433M
51,116M
Net income
40,635M
39,221M
41,224M
34,882M
33,142M
EBITDA
63,203M
74,590M
76,641M
78,456M
76,522M
Diluted EPS
194.74
187.84
197.28
166.92
158.38
Dividends Per Share
58
66
70
72
72
Total Assets
279,817M
321,979M
346,775M
389,291M
427,475M
Total liabilities
71,248M
80,531M
81,588M
110,941M
118,801M
Total equity
209,407M
240,750M
264,449M
277,684M
307,898M
Operating cash flow
32,832M
52,240M
44,743M
53,182M
58,813M
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Revenue
2,307.73M
2,543.79M
2,646.70M
2,777.44M
2,876.48M
Gross Profit
1,309.26M
1,434.13M
1,457.30M
1,469.81M
1,454.90M
Operating income
469.32M
540.87M
548.25M
501.27M
480.37M
Income before tax
452.00M
524.36M
522.61M
454.65M
481.96M
Net income
375.25M
353.87M
371.74M
320.82M
312.49M
EBITDA
583.65M
672.99M
691.11M
721.59M
721.51M
Diluted EPS
1.79
1.69
1.77
1.53
1.49
Dividends Per Share
0.53
0.59
0.63
0.66
0.67
Total Assets
2,511.14M
3,027.54M
3,132.99M
3,606.04M
3,868.55M
Total liabilities
639.39M
757.22M
737.11M
1,027.65M
1,075.12M
Total equity
1,879.26M
2,263.75M
2,389.20M
2,572.21M
2,786.40M
Operating cash flow
303.19M
471.34M
403.47M
489.13M
554.53M
Valuation Measures
Mar 2021
PER 75.16 ROA 8.11% ROE 11.31% Operating margin 16.69% Profit margin 10.86%
Key executives
Chairman, Chief Executive Officer & President:
Hisashi Ietsugu
Director, CTO & COO-LS Business Unit:
Kaoru Asano
CFO, Director & Senior Managing Executive Officer:
Yukio Nakajima
Manager-Informatics:
Yasuhiro Takachi
Executive Officer:
Keiji Fujimoto Shareholders
Baillie Gifford & Co. (5.9%)
Kobe Yamabuki Foundation (5.7%)
Nakatani Foundation (5.6%)
Nakatani Kosan YK (4.9%)
IETSUGU KAZUKO (2.9%)
WADA TAEKO (2.9%)
BlackRock Fund Advisors (2.7%)
Nomura Asset Management Co., Ltd. (2.6%)
IETSUGU FAMILY (2.2%)
The Vanguard Group, Inc. (2.2%)
Contact Details Website: http://www.sysmex.co.jp Address:
1-5-1 Wakinohama-Kaigandori,
Chuo-Ku,
Kobe,
651-0073,
Japan
Phone:
+81.78.265.0500
Related Companies
Oxford Gene Technology (Operations) Ltd.
Sysmex Medical Electronics (Shanghai) Co., Ltd.
Sysmex Wuxi Co. Ltd.
Sysmex Inostics, Inc.
Sysmex Turkey Diagnostik Sistemleri Ltd. STI
Sysmex (Malaysia) Sdn.Bhd.
Sysmex Vietnam Co. Ltd.
Sysmex Taiwan Co. Ltd.
Sysmex Suisse AG
Sysmex Slovakia sro
Sysmex Shanghai Ltd.
Sysmex RUS LLC
Sysmex Polska Sp zoo
Sysmex Philippines, Inc.
Sysmex Hungaria Kft.
Sysmex Hong Kong Ltd.
Sysmex Espana SL
Sysmex do Brasil Industria e Comercio Ltda.
Sysmex CZ sro
Sysmex Canada, Inc.
Sysmex Austria GmbH
Sysmex Middle East FZ LLC
Sysmex South Africa (Pty) Ltd.
Sysmex Inostics GmbH
Sysmex Korea Co., Ltd.
Katakura Industries Co. Ltd. /Biological Research Center/
Sysmex RA Co. Ltd.
Sysmex Europe GmbH
Sysmex Deutschland GmbH
Sysmex TMC Co., Ltd.
Competitors
bioMerieux SA
Haemonetics Corporation
Bio-Techne Corporation
Guardant Health, Inc.
Autobio Diagnostics Co., Ltd. Class A
Epigenomics AG
Biocept, Inc.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 11 Jun, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
